Beneficial homocysteine-lowering effects of NAC have also been found in a number of longer-term RCTs, with mean reductions in the range of 1045%, depending on baseline level, patient population and dosage
PMC 4076149
Dual agonists may carry slightly higher rates of GI symptoms due to dual pathway activation, though individual tolerability varies
Wegovy is an injectable form of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Nevertheless, its essential to emphasize that while research has been promising, further clinical studies are required to establish its safety and efficacy in real-world applications
The data from using these medications for weight loss are promising, with more studies currently being conducted for other uses like cardiovascular disease, fatty liver and substance use disorders